| |
Overall survival (%)
|
Univariate analysis Log-Rank p-value
|
Cox Multivariate analysis
|
|---|
|
Hazard ratio (95% CI*)
|
p-value
|
|---|
|
Surgeon class
| | | | |
|
High-volume
|
87.2
|
< 0.001
|
0.81 (0.67-0.98)
|
0.027
|
|
Others
|
81.6
|
1
|
|
Age at diagnosis
| | |
|
< 50 years old
|
90.0
|
< 0.001
|
0.87 (0.68-1.11)
|
0.267
|
|
50 to 74 years old
|
89.6
|
1
| |
|
> 74 years old
|
61.2
|
3.31 (2.71-4.04)
|
< 0.001
|
|
T stage
| | | | |
|
T1
|
90.4
|
< 0.001
|
1
| |
|
T2
|
76.6
|
1.67 (1.35-2.05)
|
< 0.001
|
|
T3 or 4
|
51.9
|
2.70 (2.00-3.63)
|
< 0.001
|
|
Node status
| | | | |
|
N0
|
90.4
|
< 0.001
|
1
|
< 0.001
|
|
N+
|
76.2
|
1.92 (1.58-2.32)
|
|
Metastasis status
| | | | |
|
M0
|
86.8
|
< 0.001
|
1
|
< 0.001
|
|
M+
|
34.8
|
3.32 (2.37-4.64)
|
|
At least one comorbidity
| | | | |
|
Yes
|
87.5
|
< 0.001
|
1.04 (0.85-1.26)
|
0.720
|
|
No
|
79.7
|
1
|
|
Circumstances of diagnosis
| | | | |
|
Screening
|
93.0
|
< 0.001
|
0.54 (0.43-0.68)
|
< 0.001
|
|
Clinical symptoms
|
83.1
|
1
|
- * CI: Confidence Interval.
